Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update
Go back to Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 222.85 -2.15 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.00 | 52 Week High | $0.52 | |||
| Open | $224.50 | 52 Week Low | $0.08 | |||
| Day High | $227.46 | P/E | N/A | |||
| Day Low | $218.51 | EPS | $-3.80 | |||
| Volume | 5,190,244 | |||||



